Study confirms GSK-Vir antibody drug reduces hospitalization, death in COVID-19 patients

Retrieved on: 2021-06-21 12:22:30

Tags for this article:

Life Sciences

Medical specialties

Health care

Monoclonal antibodies

Antiviral drugs

COVID-19 drug development

Immunology

Sotrovimab

Regeneron Pharmaceuticals

GlaxoSmithKline

GlaxoSmithKline plc

Click the tags to see associated articles and topics

Study confirms GSK-Vir antibody drug reduces hospitalization, death in COVID-19 patients. View article details on hiswai:

Excerpt

(Reuters) - GlaxoSmithKline Plc and Vir Biotechnology said on Monday final results from a late-stage study of their monoclonal antibody confirmed it ...

Article found on: www.reuters.com

View Original Article